Valuation: FDC Limited

Market Cap 5.23TCr 54Cr 47Cr 44Cr 40Cr 76Cr 78Cr 523.19Cr 205.53Cr 2.55TCr 203.81Cr 199.33Cr 8.82TCr P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 4.71TCr 49Cr 43Cr 40Cr 36Cr 69Cr 70Cr 471.67Cr 185.29Cr 2.3TCr 183.74Cr 179.7Cr 7.95TCr EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.38%
1 week-2.82%
Current month-0.88%
1 month+10.32%
3 months+17.20%
6 months+7.95%
Current year-0.71%
1 week 413.55
Extreme 413.55
435
1 month 380.2
Extreme 380.2
442
Current year 312.95
Extreme 312.95
442
1 year 312.95
Extreme 312.95
527.8
3 years 312.95
Extreme 312.95
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 16/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.82% - - 71Cr
+0.87%-3.93%+48.03%+160.13% 1,04300Cr
+1.93%-3.52%+51.70%+56.36% 60TCr
+1.86%+1.79%+33.48%+87.04% 45TCr
+0.92%-0.89%+29.81%+24.38% 33TCr
+1.45%+0.10%+33.28%+46.49% 28TCr
+0.02%-2.28%+21.63%+22.96% 26TCr
+0.98%+2.19%+24.27%+63.38% 20TCr
+1.41%+1.08%+24.08%+76.58% 17TCr
+1.37%+3.67%+2.15%-30.78% 14TCr
Average +0.96%-0.68%+29.82%+56.28% 38.63TCr
Weighted average by Cap. +1.13%-1.82%+37.46%+82.90%

Financials

2024 2025
Net sales 1.94TCr 20Cr 18Cr 16Cr 15Cr 28Cr 29Cr 194.39Cr 76Cr 948.8Cr 76Cr 74Cr 3.28TCr 2.11TCr 22Cr 19Cr 18Cr 16Cr 31Cr 31Cr 210.91Cr 83Cr 1.03TCr 82Cr 80Cr 3.55TCr
Net income 305.22Cr 3.17Cr 2.77Cr 2.56Cr 2.35Cr 4.45Cr 4.52Cr 31Cr 12Cr 149.05Cr 12Cr 12Cr 514.59Cr 266.79Cr 2.77Cr 2.42Cr 2.24Cr 2.05Cr 3.89Cr 3.95Cr 27Cr 10Cr 130.28Cr 10Cr 10Cr 449.79Cr
Net Debt -454.93Cr -4.72Cr -4.13Cr -3.82Cr -3.5Cr -6.63Cr -6.74Cr -46Cr -18Cr -222.16Cr -18Cr -17Cr -766.98Cr -514.96Cr -5.34Cr -4.67Cr -4.32Cr -3.96Cr -7.5Cr -7.63Cr -52Cr -20Cr -251.47Cr -20Cr -20Cr -868.18Cr
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
17/26/17 420.10 -0.38% 86,854
16/26/16 ₹421.70 -0.57% 1,27,975
15/26/15 ₹424.10 +0.58% 52,937
14/26/14 ₹421.65 -1.48% 81,286
13/26/13 ₹428.00 -0.99% 1,08,030
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B